Geiben-Lynn R, Frimpong-Boateng K, Letvin N
Clin Vaccine Immunol. 2011; 18(4):533-8.
PMID: 21325489
PMC: 3122565.
DOI: 10.1128/CVI.00390-10.
Lai S, Andrews L, Tollefsbol T
Methods Mol Biol. 2008; 405:23-9.
PMID: 18369814
PMC: 2423205.
DOI: 10.1007/978-1-60327-070-0_3.
Sakamoto N, Tanabe Y, Yokota T, Satoh K, Sekine-Osajima Y, Nakagawa M
J Gastroenterol Hepatol. 2007; 23(9):1437-47.
PMID: 17683479
PMC: 7166320.
DOI: 10.1111/j.1440-1746.2007.05076.x.
Zhou H, Tsai S, Tsai M
Nucl Recept Signal. 2006; 1:e008.
PMID: 16604180
PMC: 1402227.
DOI: 10.1621/nrs.01008.
Sanchez A, Perez M, Cornu T, de la Torre J
J Virol. 2005; 79(17):11071-81.
PMID: 16103158
PMC: 1193575.
DOI: 10.1128/JVI.79.17.11071-11081.2005.
Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs.
Yokota T, Sakamoto N, Enomoto N, Tanabe Y, Miyagishi M, Maekawa S
EMBO Rep. 2003; 4(6):602-8.
PMID: 12740604
PMC: 1319196.
DOI: 10.1038/sj.embor.embor840.
Inhibition of gammaherpesvirus replication by RNA interference.
Jia Q, Sun R
J Virol. 2003; 77(5):3301-6.
PMID: 12584354
PMC: 149755.
DOI: 10.1128/jvi.77.5.3301-3306.2003.
A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.
Sui G, Soohoo C, Affar E, Gay F, Shi Y, Forrester W
Proc Natl Acad Sci U S A. 2002; 99(8):5515-20.
PMID: 11960009
PMC: 122801.
DOI: 10.1073/pnas.082117599.
Stable suppression of gene expression by RNAi in mammalian cells.
Paddison P, Caudy A, Hannon G
Proc Natl Acad Sci U S A. 2002; 99(3):1443-8.
PMID: 11818553
PMC: 122210.
DOI: 10.1073/pnas.032652399.
Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells.
Dani C, Mechti N, Piechaczyk M, Lebleu B, Jeanteur P, Blanchard J
Proc Natl Acad Sci U S A. 1985; 82(15):4896-9.
PMID: 3860831
PMC: 390464.
DOI: 10.1073/pnas.82.15.4896.
Injection of mice with antibody to mouse interferon alpha/beta decreases the level of 2'-5' oligoadenylate synthetase in peritoneal macrophages.
GRESSER I, Vignaux F, Belardelli F, Tovey M, Maunoury M
J Virol. 1985; 53(1):221-7.
PMID: 2981340
PMC: 255016.
DOI: 10.1128/JVI.53.1.221-227.1985.
Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication.
Kumar R, Choubey D, Lengyel P, Sen G
J Virol. 1988; 62(9):3175-81.
PMID: 2841470
PMC: 253435.
DOI: 10.1128/JVI.62.9.3175-3181.1988.
Functional equivalents of interferon-mediated signals needed for induction of an mRNA can be generated by double-stranded RNA and growth factors.
Tiwari R, Kusari J, Sen G
EMBO J. 1987; 6(11):3373-8.
PMID: 2828026
PMC: 553793.
DOI: 10.1002/j.1460-2075.1987.tb02659.x.
Gene induction by interferons and double-stranded RNA: selective inhibition by 2-aminopurine.
Tiwari R, Kusari J, Kumar R, Sen G
Mol Cell Biol. 1988; 8(10):4289-94.
PMID: 2460741
PMC: 365501.
DOI: 10.1128/mcb.8.10.4289-4294.1988.
2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients.
Ogawa Y
Gastroenterol Jpn. 1988; 23(3):279-86.
PMID: 2456963
DOI: 10.1007/BF02779471.
Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences.
Benech P, Mory Y, Revel M, Chebath J
EMBO J. 1985; 4(9):2249-56.
PMID: 2416561
PMC: 554493.
DOI: 10.1002/j.1460-2075.1985.tb03922.x.
Development of the interferon system. I. In chicken cells development in ovo continues on time in vitro.
Sekellick M, Biggers W, Marcus P
In Vitro Cell Dev Biol. 1990; 26(10):997-1003.
PMID: 1700777
DOI: 10.1007/BF02624475.
A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.
Restifo N, Spiess P, Karp S, Mule J, Rosenberg S
J Exp Med. 1992; 175(6):1423-31.
PMID: 1588273
PMC: 1974839.
DOI: 10.1084/jem.175.6.1423.
